
New research suggests that digital breast tomosynthesis (DBT) offers significantly higher detection rates than digital mammography for radial sclerosing lesions, lobular carcinoma in situ and atypical lobular hyperplasia.
The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for
The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for sale as stand-alone products.




